Search hospitals > Michigan > Lansing
Mid-Michigan Physicians-Lansing
Claim this profileLansing, Michigan 48912
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Colorectal Cancer
Conducts research for Adenocarcinoma
Conducts research for Prostate Cancer
28 reported clinical trials
9 medical researchers
Summary
Mid-Michigan Physicians-Lansing is a medical facility located in Lansing, Michigan. This center is recognized for care of Cancer, Breast Cancer, Colorectal Cancer, Adenocarcinoma, Prostate Cancer and other specialties. Mid-Michigan Physicians-Lansing is involved with conducting 28 clinical trials across 57 conditions. There are 9 research doctors associated with this hospital, such as Ammar Sukari, Anteneh A. Tesfaye, Anthony F. Shields, and Mohammed N. Al Hallak.Area of expertise
1Cancer
Global LeaderStage III
Stage IV
Stage II
2Breast Cancer
HER2 negative
Stage IV
PR positive
Top PIs
Ammar SukariWayne State University/Karmanos Cancer Institute2 years of reported clinical research
Expert in Squamous Cell Carcinoma
Expert in Cancer
27 reported clinical trials
44 drugs studied
Anteneh A. TesfayeWayne State University/Karmanos Cancer Institute5 years of reported clinical research
Studies Colorectal Cancer
Studies Neuroendocrine Tumors
19 reported clinical trials
39 drugs studied
Anthony F. ShieldsBarbara Ann Karmanos Cancer Institute4 years of reported clinical research
Studies Solid Tumors
Studies Tumors
20 reported clinical trials
62 drugs studied
Mohammed N. Al HallakWayne State University/Karmanos Cancer Institute4 years of reported clinical research
Studies Pancreatic Cancer
Studies Colorectal Cancer
17 reported clinical trials
33 drugs studied
Clinical Trials running at Mid-Michigan Physicians-Lansing
Prostate Cancer
Gastric Cancer
Esophageal Adenocarcinoma
Anal Cancer
Esophageal Cancer
Squamous Cell Carcinoma
Anal Carcinoma
Cancer
Anal Squamous Cell Carcinoma
Anal Canal Carcinoma
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mid-Michigan Physicians-Lansing?
Mid-Michigan Physicians-Lansing is a medical facility located in Lansing, Michigan. This center is recognized for care of Cancer, Breast Cancer, Colorectal Cancer, Adenocarcinoma, Prostate Cancer and other specialties. Mid-Michigan Physicians-Lansing is involved with conducting 28 clinical trials across 57 conditions. There are 9 research doctors associated with this hospital, such as Ammar Sukari, Anteneh A. Tesfaye, Anthony F. Shields, and Mohammed N. Al Hallak.